Your browser doesn't support javascript.
loading
Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.
Kriss, Michael; Verna, Elizabeth C; Rosen, Hugo R; Lozupone, Catherine A.
Afiliação
  • Kriss M; Division of Gastroenterology & Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
  • Verna EC; GI and Liver Innate Immune Program, University of Colorado School of Medicine, Aurora, CO.
  • Rosen HR; Center for Liver Disease and Transplantation, Department of Medicine, Columbia University Medical Center, New York, NY.
  • Lozupone CA; Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA.
Transplantation ; 103(4): 668-678, 2019 04.
Article em En | MEDLINE | ID: mdl-30507741
Gut dysbiosis, defined as a maladaptive gut microbial imbalance, has been demonstrated in patients with end-stage liver disease, defined as a contributor to disease progression, and associated clinically with severity of disease and liver-related morbidity and mortality. Despite this well-recognized phenomena in patients with end-stage liver disease, the impact of gut dysbiosis and its rate of recovery following liver transplantation (LT) remains incompletely understood. The mechanisms by which alterations in the gut microbiota impact allograft metabolism and immunity, both directly and indirectly, are multifactorial and reflect the complexity of the gut-liver axis. Importantly, while research has largely focused on quantitative and qualitative changes in gut microbial composition, changes in microbial functionality (in the presence or absence of compositional changes) are of critical importance. Therefore, to translate functional microbiomics into clinical practice, one must understand not only the compositional but also the functional changes associated with gut dysbiosis and its resolution post-LT. In this review, we will summarize critical advances in functional microbiomics in LT recipients as they apply to immune-mediated allograft injury, posttransplant complications, and disease recurrence, while highlighting potential areas for microbial-based therapeutics in LT recipients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Microbioma Gastrointestinal Tipo de estudo: Etiology_studies / Qualitative_research Limite: Humans Idioma: En Revista: Transplantation Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Microbioma Gastrointestinal Tipo de estudo: Etiology_studies / Qualitative_research Limite: Humans Idioma: En Revista: Transplantation Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos